Literature DB >> 31345337

Immune Checkpoint Inhibitors in ROS1-Rearranged Non-Small Cell Lung Cancer: A Report of Two Cases.

Aditya Jain1, Naomi Fujioka1, Manish Patel2.   

Abstract

Entities:  

Year:  2019        PMID： 31345337     DOI： 10.1016/j.jtho.2019.03.008

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  6 in total

1.  Short-term response to immune-chemotherapy and immune features of a ceritinib-resistant patient with ROS1-rearranged lung adenocarcinoma.

Authors:  Dongsheng Yue; Juanjuan Qian; Zhipeng Chen; Bin Zhang; Peng Chen; Lei Zhang; Jingjing Li; Henghui Zhang; Changli Wang
Journal:  J Immunother Cancer       Date:  2021-02       Impact factor: 13.751

2.  Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers.

Authors:  Noura J Choudhury; Jaime L Schneider; Tejas Patil; Viola W Zhu; Debra A Goldman; Soo-Ryum Yang; Christina J Falcon; Andrew Do; Yunan Nie; Andrew J Plodkowski; Jamie E Chaft; Subba R Digumarthy; Natasha Rekhtman; Maria E Arcila; Alexia Iasonos; Sai-Hong I Ou; Jessica J Lin; Alexander Drilon
Journal:  JTO Clin Res Rep       Date:  2021-05-18

Review 3.  [Research Progress of Immunotherapy for Non-small Cell Lung Cancer 
with Drive Gene Mutation].

Authors:  Renfang Deng; Yue Zeng; Yue Pan; Chunhong Hu; Fang Wu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-03-20

4.  Rare MYH9-ROS1 Fusion Gene-Positive Lung Adenocarcinoma Showing Response to Entrectinib Treatment: A Case Study.

Authors:  Takeshi Tsuda; Naoki Takata; Takahiro Hirai; Yasuaki Masaki; Shin Ishizawa; Hirokazu Taniguchi
Journal:  Case Rep Oncol       Date:  2022-03-31

5.  Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy.

Authors:  Pasquale Pisapia; Antonino Iaccarino; Caterina De Luca; Gennaro Acanfora; Claudio Bellevicine; Roberto Bianco; Bruno Daniele; Luisa Ciampi; Marco De Felice; Teresa Fabozzi; Luigi Formisano; Pasqualina Giordano; Cesare Gridelli; Giovanni Pietro Ianniello; Annamaria Libroia; Paolo Maione; Mariantonia Nacchio; Fabio Pagni; Giovanna Palmieri; Francesco Pepe; Gianluca Russo; Maria Salatiello; Antonio Santaniello; Rachele Scamarcio; Davide Seminati; Michele Troia; Giancarlo Troncone; Elena Vigliar; Umberto Malapelle
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208

6.  Immune checkpoint inhibitors and driver oncogenes in non-small cell lung cancer.

Authors:  Yosuke Miura; Norimitsu Kasahara; Noriaki Sunaga
Journal:  Transl Cancer Res       Date:  2019-12       Impact factor: 1.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.